ES2224273T3
(es)
|
1996-09-30 |
2005-03-01 |
University Of Arkansas |
Metodo para producir inmunidad activa por medio de un conjugado de vacuna.
|
WO1999010001A1
(fr)
*
|
1997-08-21 |
1999-03-04 |
Takara Shuzo Co., Ltd. |
Agents cancerostatiques
|
EP2295065B1
(en)
*
|
1998-02-20 |
2013-10-09 |
The University of Miami |
Modified heat shock protein-antigenic peptide complex
|
DE69940731D1
(de)
*
|
1998-05-26 |
2009-05-28 |
Genitrix Llc |
Zusammensetzungen und verfahren zur modulation einer immunantwort auf ein antigen durch verabreichung von zytokine-beladenen zellen
|
US7030211B1
(en)
*
|
1998-07-08 |
2006-04-18 |
Gemvax As |
Antigenic peptides derived from telomerase
|
US6884785B2
(en)
*
|
1999-06-17 |
2005-04-26 |
The Scripps Research Institute |
Compositions and methods for the treatment or prevention of autoimmune diabetes
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
GB9930591D0
(en)
*
|
1999-12-23 |
2000-02-16 |
Univ London |
Component for vaccine
|
JP5087201B2
(ja)
*
|
2000-08-03 |
2012-12-05 |
ジョンズ・ホプキンス・ユニバーシティ |
抗原に小胞体シャペロンポリペプチドを連結した分子ワクチン
|
WO2002041913A1
(en)
*
|
2000-11-27 |
2002-05-30 |
Jens Christian Jensenius |
Collectins as adjuvants
|
US7507724B2
(en)
|
2001-01-16 |
2009-03-24 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
AU2002350409A1
(en)
*
|
2001-10-26 |
2003-05-06 |
Uffe Holmskov |
Surfactant protein-d and atherosclerosis
|
WO2004006837A2
(en)
*
|
2002-07-12 |
2004-01-22 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
US20090110702A1
(en)
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
US7425620B2
(en)
|
2002-08-14 |
2008-09-16 |
Scott Koenig |
FcγRIIB-specific antibodies and methods of use thereof
|
US20040091503A1
(en)
*
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
MXPA05001953A
(es)
*
|
2002-08-20 |
2005-06-22 |
Genitrix Llc |
Composiciones de lecitina y metodos para modular una respuesta inmune a un antigeno.
|
JP4545151B2
(ja)
*
|
2003-02-06 |
2010-09-15 |
シーラス コーポレイション |
非食細胞中への侵入について減弱化されているリステリア、そのリステリアを含むワクチン、およびそれらの使用法
|
US7695725B2
(en)
*
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
AU2004224425B2
(en)
*
|
2003-02-06 |
2010-06-24 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
EP1644048B1
(en)
*
|
2003-05-05 |
2015-04-29 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
GB0315991D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Dakocytomation Denmark As |
Standard
|
US7842289B2
(en)
*
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
WO2006073970A2
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
EP1846026A4
(en)
*
|
2005-01-26 |
2008-07-02 |
Univ Johns Hopkins |
ANTICANCER DNA VACCINE USING PLASMID CODING ANTIGEN AND CALRETICULIN SUCH AS MUTANT ONCOPROTEINS
|
US20060188526A1
(en)
*
|
2005-02-24 |
2006-08-24 |
Cunnion Kenji M |
Method for enhancing the immune response to Staphylococcus aureus infection
|
RU2420569C2
(ru)
|
2005-11-29 |
2011-06-10 |
Актогеникс Нв |
Индукция толерантности к антигенам через слизистую
|
PL2347775T3
(pl)
|
2005-12-13 |
2020-11-16 |
President And Fellows Of Harvard College |
Rusztowania do przeszczepiania komórek
|
EP1984004A4
(en)
*
|
2006-01-17 |
2010-03-03 |
Sloan Kettering Inst Cancer |
THE THERAPY REINFORCING GLUCAN
|
CA2651962A1
(en)
*
|
2006-05-12 |
2007-12-21 |
Oklahoma Medical Research Foundation |
Anthrax compositions and methods of use and production
|
EP2029173B1
(en)
|
2006-06-26 |
2016-07-20 |
MacroGenics, Inc. |
Fc riib-specific antibodies and methods of use thereof
|
WO2008024844A2
(en)
*
|
2006-08-22 |
2008-02-28 |
The Johns Hopkins University |
Anticancer combination therapies
|
EP2774621B1
(en)
|
2007-01-25 |
2018-01-24 |
Intrexon Actobiotics NV |
Treatment of immune disease by mucosal delivery of antigens
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
WO2009039125A1
(en)
*
|
2007-09-17 |
2009-03-26 |
The Schepens Eye Research Institute, Inc. |
Use of ocular neuropeptides as immune adjuvants
|
WO2009102465A2
(en)
|
2008-02-13 |
2009-08-20 |
President And Fellows Of Harvard College |
Continuous cell programming devices
|
JP2011513399A
(ja)
|
2008-03-03 |
2011-04-28 |
ザ ユニバーシティー オブ マイアミ |
同種癌細胞による免疫療法
|
WO2009117116A2
(en)
|
2008-03-20 |
2009-09-24 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
IN2012DN06589A
(ja)
|
2010-01-19 |
2015-10-23 |
Harvard College |
|
JP6104806B2
(ja)
|
2010-10-06 |
2017-03-29 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
材料に基づく細胞治療のための注射可能孔形成性ハイドロゲル
|
JP2014523914A
(ja)
|
2011-07-18 |
2014-09-18 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作された微生物標的化分子およびその使用
|
RS59898B1
(sr)
|
2011-10-17 |
2020-03-31 |
Massachusetts Inst Technology |
Intraćelijsko davanje
|
WO2013130875A1
(en)
|
2012-02-29 |
2013-09-06 |
President And Fellows Of Harvard College |
Rapid antibiotic susceptibility testing
|
LT2838515T
(lt)
|
2012-04-16 |
2020-03-10 |
President And Fellows Of Harvard College |
Mezoporinės silico dioksido kompozicijos, skirtos imuninio atsako moduliavimui
|
EP2674167A1
(en)
*
|
2012-06-14 |
2013-12-18 |
PLS-Design GmbH |
Controlled activation of complement components for use as endogenous adjuvant
|
EP2976642A4
(en)
|
2013-03-15 |
2016-09-21 |
Harvard College |
METHODS AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR CAPTURE OF A TARGET ENTITY
|
CA2913155A1
(en)
|
2013-05-21 |
2014-11-27 |
President And Fellows Of Harvard College |
Engineered heme-binding compositions and uses thereof
|
JP6502940B2
(ja)
|
2013-08-16 |
2019-04-17 |
マサチューセッツ インスティテュート オブ テクノロジー |
細胞への物質の選択的送達
|
EP3083658B1
(en)
|
2013-12-18 |
2019-05-08 |
President and Fellows of Harvard College |
Crp capture/detection of gram positive bacteria
|
JP7348708B2
(ja)
|
2014-04-30 |
2023-09-21 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
組み合わせワクチン装置および癌細胞を殺滅する方法
|
SG10201903912XA
(en)
|
2014-10-31 |
2019-05-30 |
Massachusetts Inst Technology |
Delivery of biomolecules to immune cells
|
CN107002089B
(zh)
|
2014-11-14 |
2021-09-07 |
麻省理工学院 |
化合物和组合物向细胞中的破坏和场实现的递送
|
WO2016115179A1
(en)
|
2015-01-12 |
2016-07-21 |
Massachusetts Institute Of Technology |
Gene editing through microfluidic delivery
|
US11786457B2
(en)
|
2015-01-30 |
2023-10-17 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
MX2017010159A
(es)
|
2015-02-06 |
2017-12-18 |
Heat Biologics Inc |
Vector que expresa conjuntamente vacunas y moléculas coestimuladoras.
|
EP3280464A4
(en)
|
2015-04-10 |
2018-09-26 |
President and Fellows of Harvard College |
Immune cell trapping devices and methods for making and using the same
|
AU2016289530B2
(en)
|
2015-07-09 |
2021-05-06 |
Massachusetts Institute Of Technology |
Delivery of materials to anucleate cells
|
CN108289928A
(zh)
|
2015-08-06 |
2018-07-17 |
哈佛大学校长及研究员协会 |
改进的微生物-结合分子和其用途
|
WO2017041051A1
(en)
|
2015-09-04 |
2017-03-09 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to cells comprising a cell wall
|
CN109072197A
(zh)
|
2016-02-06 |
2018-12-21 |
哈佛学院校长同事会 |
重塑造血巢以重建免疫
|
WO2017143024A2
(en)
|
2016-02-16 |
2017-08-24 |
President And Fellows Of Harvard College |
Pathogen vaccines and methods of producing and using the same
|
WO2018013797A1
(en)
|
2016-07-13 |
2018-01-18 |
President And Fellows Of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
CA3040123A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
WO2018187260A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
US20200262879A1
(en)
|
2017-09-11 |
2020-08-20 |
Insideoutbio, Inc. |
Methods and compositions to enhance the immunogenicity of tumors
|
US20210403519A1
(en)
|
2018-11-02 |
2021-12-30 |
Insideoutbio, Inc. |
Methods and compositions to induce or suppress immune responses through the use of membrane bound complement split products
|